Cargando…

Save the kidneys in COVID-19

Detalles Bibliográficos
Autores principales:	Knight, Philip P., Deep, Akash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676416/ https://www.ncbi.nlm.nih.gov/pubmed/33214677 http://dx.doi.org/10.1038/s41390-020-01280-x

Ejemplares similares

UK COVID-19 public inquiry needed to learn lessons and save lives
por: Goodman, Jo, et al.
Publicado: (2021)

World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis
por: Ntoumi, Francine, et al.
Publicado: (2022)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

The impact of COVID-19 on kidney transplantation
por: Alasfar, Sami, et al.
Publicado: (2020)

Remdesivir saves lives. Were 3 years needed to learn that?
por: Kalil, Andre C
Publicado: (2023)

COVID-19 vaccination in kidney transplant recipients
por: Caillard, Sophie, et al.
Publicado: (2021)

COVID-19 vaccination in patients with immunity-mediated kidney disease
por: Prendecki, Maria, et al.
Publicado: (2021)

Lymphedema self-care: economic cost savings and opportunities to improve adherence
por: Karaca-Mandic, Pinar, et al.
Publicado: (2023)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Kidney involvement in COVID-19 and rationale for extracorporeal therapies
por: Ronco, Claudio, et al.
Publicado: (2020)

Risk stratification of patients with COVID-19 in the community
por: Knight, Stephen R, et al.
Publicado: (2022)

More than honour, humanitarian health-care workers need life-saving protection
por: Langlois, Etienne V, et al.
Publicado: (2021)

From petri dishes to politics – a multi-pronged approach is essential for saving endangered species
por: Roth, Terri L., et al.
Publicado: (2018)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Novel viruses, old data, and basic principles: how to save lives and avoid harm amid the unknown
por: Rose, Michael R, et al.
Publicado: (2020)

COVID-19: trainee perspectives from unprecedented changes on the Paediatric Intensive Care Unit (PICU)
por: Siva, Naren, et al.
Publicado: (2021)

The resolve to save lives sodium reduction framework; aligning global efforts to reduce the global burden of cardiovascular disease
por: Abdel-Gawad, Nora, et al.
Publicado: (2022)

Banning highly hazardous pesticides saves the lives of young people, particularly females, in low- and middle-income countries
por: Schölin, Lisa, et al.
Publicado: (2023)

Long COVID and kidney disease
por: Yende, Sachin, et al.
Publicado: (2021)

Effect of adult COVID-19 surge on the provision of kidney replacement therapy in children
por: Deep, Akash
Publicado: (2020)

Often forgotten, transport modality to dialysis may be life-saving
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
por: Wang, Stephen Y, et al.
Publicado: (2022)

Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease
por: Kazama, Itsuro
Publicado: (2022)

COVID-19 and clean air: an opportunity for radical change
por: Landrigan, Philip J, et al.
Publicado: (2020)

Divergent effects of acute versus chronic glucocorticoids in COVID-19
por: Robinson, Philip C, et al.
Publicado: (2021)

The UK hibernated pandemic influenza research portfolio: triggered for COVID-19
por: Simpson, Colin R, et al.
Publicado: (2020)

What does endemic COVID-19 mean for the future of rituximab?
por: Liew, David F L, et al.
Publicado: (2022)

Severe COVID-19 in pregnancy is almost exclusively limited to unvaccinated women – time for policies to change
por: Engjom, Hilde, et al.
Publicado: (2022)

The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic
por: Robinson, Philip C., et al.
Publicado: (2020)

Patients with gout: an under-recognised group at high risk of COVID-19
por: Dalbeth, Nicola, et al.
Publicado: (2021)

Racial and ethnic differences in COVID-19 outcomes: a call to action
por: Robinson, Philip C, et al.
Publicado: (2022)

Cancer and COVID-19: what do we really know?
por: Poortmans, Philip M, et al.
Publicado: (2020)

Sulfasalazine: a risk factor for severe COVID-19?
por: Konig, Maximilian F, et al.
Publicado: (2022)

COVID-19 and its impact on the kidney and the nephrology community
por: Soler, María José, et al.
Publicado: (2021)

Preventive medicine in rheumatology: COVID-19 and its lessons for better health outcomes
por: Liew, David F L, et al.
Publicado: (2022)

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
por: Krause, Philip R, et al.
Publicado: (2020)

Studying the coagulopathy of COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2022)

Detecting chronic kidney disease by electrocardiography
por: Kooman, Jeroen P.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2vkgt4kku00li2v6b8gch20dr5